Please provide your email address to receive an email when new articles are posted on . Glucagon-like peptide-1 receptor agonists were associated with a higher risk for aspiration pneumonia after ...

People on GLP-1 receptor agonists (RAs) had a significantly higher risk of aspiration pneumonia after undergoing gastrointestinal endoscopy, researchers reported. Compared with 0.63% of non-users, ...

Please provide your email address to receive an email when new articles are posted on . GLP-1RA use prior to upper endoscopy was linked to increased risk for retained gastric contents. A 24-hour clear ...

Increased vigilance may be warranted among patients with mucosal damage for future Parkinson disease risk. Patients with a history of upper gastrointestinal (GI) mucosal damage have an increased risk ...

Researchers have linked upper gastrointestinal tract damage to a higher risk for developing Parkinson’s disease. The report, published Sept. 5 in JAMA Network Open, showed that mucosal damage seen on ...

Encountering retained gastric contents during esophagogastroduodenoscopy (EGD) is more common in patients taking glucagon-like peptide 1 receptor agonists (GLP-1 RAs) but rarely leads to procedure ...

Use upper endoscopy wisely Inappropriate endoscopy use generates unnecessary costs and exposes patients to harms without improving outcomes. Although upper endoscopy is commonly used in the diagnosis ...

Physicians and physician groups have expressed concern surrounding procedures, especially those involving anesthesia, in patients taking glucagon-like peptide 1 receptor agonist weight loss ...

Doctors may perform an upper gastrointestinal endoscopy to diagnose and help treat stomach ulcers. During the procedure, a healthcare professional inserts an endoscope through the mouth and into the ...

A consensus on major and minor key performance indicators (KPIs) was established to improve the quality of upper gastrointestinal (GI) endoscopy and reduce post-endoscopy upper GI cancer. The adoption ...